Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-29 16:54:23 - browse：5439

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Google and Epic fight stronger regulation of AI in health care

WSS

Anesthesiologist group: stop taking Ozempic before surgery

Hollywood unions extend contract negotiations for actors

Peter Hotez and the public health issue of online harassment

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Biden tests positive for Covid

Startup Neumora takes a novel depression drug to Phase 3

Wikipedia

Wikipedia

focus

Cancer drug shortages should be causing more outrage

A public scorecard can help hold safety

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Sanders adds drug shortage policies to pandemic preparedness bill

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare has a new plan to address drug shortages

Heart attack and stroke risk calculators need revising

Doctors find melanoma drugs effective against rare brain cancer

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

At Orexo, a ‘turning point’ for everything but digital health

leisure time

After affirmative action ruling, medical educators look to 'holistic review'

Continuity nursing helped my family in our darkest PICU moments

Hollywood unions extend contract negotiations for actors

Medicare has a new plan to address drug shortages

Custom gene therapy hints at new path for rare disease treatments

Hollywood unions extend contract negotiations for actors

leisure time

hotspot

leisure time

leisure time